Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Current Ratio 2006-2018 | GILD

Current and historical current ratio for Gilead Sciences (GILD) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Gilead Sciences current ratio for the three months ending December 31, 2018 was 3.38.
Gilead Sciences Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $35.84B $10.61B 3.38
2018-09-30 $34.92B $10.12B 3.45
2018-06-30 $32.73B $10.91B 3.00
2018-03-31 $30.26B $10.67B 2.84
2017-12-31 $31.82B $11.64B 2.74
2017-09-30 $35.32B $9.60B 3.68
2017-06-30 $28.59B $8.49B 3.37
2017-03-31 $21.42B $8.28B 2.59
2016-12-31 $19.59B $9.22B 2.13
2016-09-30 $21.43B $11.07B 1.94
2016-06-30 $18.35B $10.44B 1.76
2016-03-31 $19.27B $10.91B 1.77
2015-12-31 $24.76B $9.89B 2.50
2015-09-30 $25.91B $9.36B 2.77
2015-06-30 $18.09B $8.93B 2.03
2015-03-31 $20.06B $7.43B 2.70
2014-12-31 $17.71B $5.76B 3.08
2014-09-30 $12.56B $6.06B 2.08
2014-06-30 $15.50B $6.23B 2.49
2014-03-31 $12.97B $5.92B 2.19
2013-12-31 $7.00B $6.41B 1.09
2013-09-30 $6.97B $4.90B 1.42
2013-06-30 $7.07B $4.94B 1.43
2013-03-31 $6.66B $4.29B 1.55
2012-12-31 $6.16B $4.24B 1.45
2012-09-30 $5.88B $4.80B 1.23
2012-06-30 $5.84B $4.99B 1.17
2012-03-31 $5.83B $4.19B 1.39
2011-12-31 $13.92B $2.52B 5.54
2011-09-30 $6.15B $2.22B 2.76
2011-06-30 $6.22B $2.31B 2.69
2011-03-31 $6.85B $2.77B 2.47
2010-12-31 $5.71B $2.47B 2.32
2010-09-30 $6.03B $2.59B 2.33
2010-06-30 $5.71B $3.11B 1.84
2010-03-31 $5.12B $1.89B 2.72
2009-12-31 $4.81B $1.87B 2.57
2009-09-30 $4.30B $1.89B 2.28
2009-06-30 $4.00B $1.78B 2.25
2009-03-31 $4.62B $1.26B 3.66
2008-12-31 $4.28B $1.22B 3.50
2008-09-30 $4.33B $1.26B 3.44
2008-06-30 $3.67B $2.45B 1.50
2008-03-31 $2.95B $0.94B 3.14
2007-12-31 $3.03B $0.74B 4.11
2007-09-30 $2.55B $0.69B 3.68
2007-06-30 $2.45B $0.75B 3.26
2007-03-31 $2.44B $0.71B 3.44
2006-12-31 $2.43B $0.76B 3.18
2006-09-30 $4.03B $0.58B 6.93
2006-06-30 $2.49B $0.51B 4.91
2006-03-31 $3.38B $0.42B 8.00
2005-12-31 $3.09B $0.47B 6.65
2005-09-30 $2.30B $0.27B 8.58
2005-06-30 $2.39B $0.26B 9.13
2005-03-31 $2.07B $0.27B 7.66
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $80.369B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $110.723B 12.48
Celgene (CELG) United States $65.799B 12.16
Illumina (ILMN) United States $47.313B 56.30
Biogen (BIIB) United States $45.284B 8.77
Vertex Pharmaceuticals (VRTX) United States $44.835B 60.06
Regeneron Pharmaceuticals (REGN) United States $37.606B 17.47
Alexion Pharmaceuticals (ALXN) United States $29.581B 18.33
Incyte (INCY) United States $16.158B 150.82
BioMarin Pharmaceutical (BMRN) United States $15.340B 0.00
Exact Sciences (EXAS) United States $11.814B 0.00
Seattle Genetics (SGEN) United States $11.383B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.292B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
QIAGEN (QGEN) Netherlands $8.734B 28.90
Sarepta Therapeutics (SRPT) United States $8.419B 0.00
Moderna (MRNA) United States $8.126B 0.00
Bluebird Bio (BLUE) United States $7.643B 0.00
Bio-Techne Corp (TECH) United States $7.248B 48.83
BeiGene (BGNE) Cayman Islands $7.232B 0.00
Exelixis (EXEL) United States $6.449B 14.97
Amarin (AMRN) Ireland $5.938B 0.00
Galapagos (GLPG) Belgium $5.892B 0.00
Guardant Health (GH) United States $5.733B 0.00
Alkermes (ALKS) Ireland $5.370B 0.00
Array BioPharma (ARRY) United States $5.001B 0.00
Ascendis Pharma (ASND) Denmark $4.724B 0.00
Horizon Pharma Public (HZNP) Ireland $4.659B 13.80
Spark Therapeutics (ONCE) United States $4.199B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.893B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.887B 0.00
China Biologic Products (CBPO) China $3.865B 23.95
ACADIA Pharmaceuticals (ACAD) United States $3.506B 0.00
Blueprint Medicines (BPMC) United States $3.424B 0.00
Allogene Therapeutics (ALLO) United States $3.272B 0.00
Immunomedics (IMMU) United States $3.233B 0.00
Global Blood Therapeutics (GBT) United States $3.178B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.112B 0.00
Amicus Therapeutics (FOLD) United States $2.973B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.834B 0.00
Emergent Biosolutions (EBS) United States $2.714B 22.57
Intercept Pharmaceuticals (ICPT) United States $2.688B 0.00
Ligand Pharmaceuticals (LGND) United States $2.625B 19.60
Repligen (RGEN) United States $2.523B 77.36
Akcea Therapeutics (AKCA) United States $2.518B 0.00
Insmed (INSM) United States $2.451B 0.00
Genomic Health (GHDX) United States $2.433B 62.20
Reata Pharmaceuticals (RETA) United States $2.383B 0.00
Halozyme Therapeutics (HALO) United States $2.383B 0.00
Myriad Genetics (MYGN) United States $2.378B 24.22
Denali Therapeutics (DNLI) United States $2.319B 0.00
Mirati Therapeutics (MRTX) United States $2.270B 0.00
Arena Pharmaceuticals (ARNA) United States $2.256B 0.00
Acceleron Pharma (XLRN) United States $2.189B 0.00
Medicines (MDCO) United States $2.169B 0.00
UniQure (QURE) Netherlands $2.072B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.022B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.993B 0.00
MyoKardia (MYOK) United States $1.978B 0.00
AnaptysBio (ANAB) United States $1.966B 0.00
REGENXBIO (RGNX) United States $1.926B 20.00
NeoGenomics (NEO) United States $1.923B 155.15
Zai Lab Unsponsored ADR (ZLAB) China $1.758B 0.00
Audentes Therapeutics (BOLD) United States $1.749B 0.00
Allakos (ALLK) United States $1.690B 0.00
Atara Biotherapeutics (ATRA) United States $1.546B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.534B 0.00
Alector (ALEC) United States $1.461B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.448B 0.00
Innoviva (INVA) United States $1.392B 3.84
Cambrex (CBM) United States $1.368B 14.73
Lion Biotechnologies (IOVA) United States $1.357B 0.00
Editas Medicine (EDIT) United States $1.347B 0.00
InflaRx (IFRX) Germany $1.340B 0.00
Puma Biotechnology (PBYI) United States $1.337B 0.00
Myovant Sciences (MYOV) United Kingdom $1.319B 0.00
Aimmune Therapeutics (AIMT) United States $1.309B 0.00
Rubius Therapeutics (RUBY) United States $1.267B 0.00
Sangamo Therapeutics (SGMO) United States $1.227B 0.00
Apellis Pharmaceuticals (APLS) United States $1.221B 0.00
Epizyme (EPZM) United States $1.153B 0.00
Gossamer Bio (GOSS) United States $1.127B 0.00
Clovis Oncology (CLVS) United States $1.104B 0.00
Fate Therapeutics (FATE) United States $1.102B 0.00
Codexis (CDXS) United States $1.100B 0.00
NGM BIOPHARMACT (NGM) United States $1.054B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.043B 0.00
Eidos Therapeutics (EIDX) United States $1.025B 0.00
Coherus BioSciences (CHRS) United States $0.983B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.971B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.968B 0.00
Genfit SA (GNFT) France $0.964B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.955B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.942B 0.00
RA PHARMCTL INC (RARX) United States $0.926B 0.00
WAVE Life Sciences (WVE) Singapore $0.921B 0.00
Twist Bioscience (TWST) United States $0.921B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.911B 36.83
Rhythm Pharmaceuticals (RYTM) United States $0.893B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.873B 0.00
Cellectis (CLLS) France $0.857B 0.00
ANI Pharmaceuticals (ANIP) United States $0.825B 15.11
Y-mAbs Therapeutics (YMAB) United States $0.825B 0.00
Retrophin (RTRX) United States $0.817B 0.00
Vericel (VCEL) United States $0.780B 0.00
Intellia Therapeutics (NTLA) United States $0.771B 0.00
Athenex (ATNX) United States $0.760B 0.00
Cara Therapeutics (CARA) United States $0.748B 0.00
Arvinas (ARVN) United States $0.732B 0.00
G1 THERAPEUTICS (GTHX) United States $0.725B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.718B 0.00
Intra-Cellular Therapies (ITCI) United States $0.713B 0.00
Principia Biopharma (PRNB) United States $0.698B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.675B 0.00
Precision BioSciences (DTIL) United States $0.666B 0.00
Viking Therapeutics (VKTX) United States $0.628B 0.00
ObsEva SA (OBSV) Switzerland $0.625B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.621B 0.00
Stemline Therapeutics (STML) United States $0.610B 0.00
MeiraGTx Holdings (MGTX) United States $0.600B 0.00
Revance Therapeutics (RVNC) United States $0.598B 0.00
Kura Oncology (KURA) United States $0.594B 0.00
Heska (HSKA) United States $0.589B 52.85
Zealand Pharma (ZEAL) Denmark $0.578B 6.43
Synthorx (THOR) United States $0.575B 0.00
DBV Technologies (DBVT) France $0.541B 0.00
Acorda Therapeutics (ACOR) United States $0.540B 6.99
Zymeworks (ZYME) Canada $0.538B 0.00
Axsome Therapeutics (AXSM) United States $0.530B 0.00
UROGEN PHARMA (URGN) United States $0.519B 0.00
Magenta Therapeutics (MGTA) United States $0.519B 0.00
Mesoblast (MESO) Australia $0.519B 0.00
Cytokineticsorporated (CYTK) United States $0.496B 0.00
Arcus Biosciences (RCUS) United States $0.490B 0.00
Krystal Biotech (KRYS) United States $0.487B 0.00
AVROBIO (AVRO) United States $0.482B 0.00
Anika Therapeutics (ANIK) United States $0.466B 17.62
Replimune (REPL) United States $0.462B 0.00
Scholar Rock Holding (SRRK) United States $0.461B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.461B 0.00
Sorrento Therapeutics (SRNE) United States $0.457B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.454B 0.00
MediciNova (MNOV) United States $0.453B 0.00
CytomX Therapeutics (CTMX) United States $0.452B 0.00
Five Prime Therapeutics (FPRX) United States $0.452B 0.00
Senesco Technologies (ELOX) United States $0.448B 0.00
PDL BioPharma (PDLI) United States $0.446B 9.94
Prothena (PRTA) Ireland $0.446B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.444B 0.00
KALEIDO BIOSCI (KLDO) $0.443B 0.00
CYCLERION THERA (CYCN) United States $0.424B 0.00
Dynavax Technologies (DVAX) United States $0.424B 0.00
Adverum Biotechnologies (ADVM) United States $0.418B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.417B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Abeona Therapeutics (ABEO) United States $0.396B 0.00
Albireo Pharma (ALBO) United States $0.384B 0.00
Gritstone Oncology (GRTS) United States $0.378B 0.00
Kezar Life Sciences (KZR) United States $0.378B 0.00
Inovio Pharmaceuticals (INO) United States $0.377B 0.00
STEALTH BIOTHER (MITO) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Merus (MRUS) Netherlands $0.362B 0.00
Geron (GERN) United States $0.358B 0.00
Agenus (AGEN) United States $0.349B 0.00
BioDelivery Sciences (BDSI) United States $0.347B 0.00
Kindred Biosciences (KIN) United States $0.344B 0.00
UNITY Biotechnology (UBX) $0.342B 0.00
XBiotech (XBIT) United States $0.339B 0.00
Solid Biosciences (SLDB) United States $0.328B 0.00
AC Immune SA (ACIU) Switzerland $0.327B 0.00
BeyondSpring (BYSI) United States $0.326B 0.00
Constellation Pharmaceuticals (CNST) United States $0.321B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.315B 0.00
PHASEBIO PHARMA (PHAS) United States $0.313B 0.00
MannKind (MNKD) United States $0.300B 0.00
Seres Therapeutics (MCRB) United States $0.287B 0.00
Aduro Biotech (ADRO) United States $0.282B 0.00
Kadmon Holdings (KDMN) United States $0.280B 0.00
LogicBio Therapeutics (LOGC) United States $0.273B 0.00
Evelo Biosciences (EVLO) United States $0.271B 0.00
Kodiak Sciences (KOD) United States $0.266B 0.00
Urovant Sciences (UROV) United States $0.261B 0.00
Enochian BioSciences (ENOB) United States $0.260B 0.00
Avid Bioservices (CDMO) United States $0.259B 0.00
Kala Pharmaceuticals (KALA) United States $0.256B 0.00
Cerecor (CERC) United States $0.248B 0.00
ResTORbio (TORC) United States $0.248B 0.00
Kamada (KMDA) Israel $0.246B 11.13
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
Athersys (ATHX) United States $0.244B 0.00
Novavax (NVAX) United States $0.242B 0.00
Arsanis (XFOR) United States $0.237B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.234B 0.00
ChromaDex (CDXC) United States $0.233B 0.00
Palatin Technologies (PTN) United States $0.231B 114.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Protagonist Therapeutics (PTGX) United States $0.230B 0.00
Syros Pharmaceuticals (SYRS) United States $0.224B 0.00
ADMA Biologics Inc (ADMA) United States $0.219B 0.00
OSMOTICA PHARM (OSMT) United States $0.219B 0.00
Cel-Sci (CVM) United States $0.218B 0.00
Celcuity (CELC) United States $0.217B 0.00
Gamida Cell (GMDA) Israel $0.215B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
Spero Therapeutics (SPRO) United States $0.214B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.213B 0.00
OvaScience (MLND) United States $0.213B 0.00
Mersana Therapeutics (MRSN) United States $0.212B 0.00
Axovant Sciences (AXGT) United Kingdom $0.210B 0.00
Intec Pharma (NTEC) Israel $0.205B 0.00
Celyad SA (CYAD) Belgium $0.202B 0.00
CorMedix Inc (CRMD) United States $0.202B 0.00
TOCAGEN INC (TOCA) United States $0.200B 0.00
VBI Vaccines (VBIV) United States $0.195B 0.00
Synlogic (SYBX) United States $0.194B 0.00
BioTime (BTX) United States $0.188B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.185B 0.00
Pfenex (PFNX) United States $0.183B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Cue Biopharma (CUE) United States $0.175B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.174B 0.00
Enzo Biochem (ENZ) United States $0.173B 0.00
Mustang Bio (MBIO) United States $0.171B 0.00
Menlo Therapeutics (MNLO) United States $0.169B 0.00
Arbutus Biopharma (ABUS) Canada $0.168B 0.00
Verastem (VSTM) United States $0.168B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
BioXcel Therapeutics (BTAI) United States $0.157B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Chiasma (CHMA) United States $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.145B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.144B 0.00
Anavex Life Sciences (AVXL) United States $0.139B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.138B 0.00
Allena Pharmaceuticals (ALNA) United States $0.136B 0.00
Trevena (TRVN) United States $0.135B 0.00
Eton Pharmaceuticals (ETON) United States $0.135B 0.00
Checkpoint Therapeutics (CKPT) United States $0.134B 0.00
VolitionRX (VNRX) Singapore $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.131B 0.00
Liquidia Technologies (LQDA) United States $0.128B 0.00
Aptinyx (APTX) United States $0.128B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.127B 0.00
Provention Bio (PRVB) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.121B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.112B 0.00
Neothetics (EVFM) United States $0.111B 0.00
Unum Therapeutics (UMRX) United States $0.109B 0.00
XOMA (XOMA) United States $0.108B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.105B 0.00
INMUNE BIO INC (INMB) United States $0.104B 0.00
Catalyst Biosciences (CBIO) United States $0.103B 0.00
Selecta Biosciences (SELB) United States $0.101B 0.00
Fortress Biotech (FBIO) United States $0.100B 0.00
Cohbar (CWBR) United States $0.097B 0.00
Dyadic (DYAI) United States $0.094B 0.00
Equillium (EQ) United States $0.094B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.094B 0.00
Signal Genetics (MGEN) United States $0.090B 0.00
NantKwest (NK) United States $0.089B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.088B 0.00
Applied Genetic Technologies (AGTC) United States $0.087B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
SESEN BIO, INC (SESN) United States $0.083B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.082B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 85.00
Alcobra (ARCT) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.077B 0.00
Aptose Biosciences (APTO) Canada $0.077B 0.00
OVID THERAPEUTC (OVID) United States $0.076B 0.00
Eyenovia (EYEN) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Zosano Pharma (ZSAN) United States $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.066B 16.08
Apricus Biosciences (SEEL) United States $0.065B 0.00
Cidara Therapeutics (CDTX) United States $0.064B 0.00
Alimera Sciences (ALIM) United States $0.064B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
VTv Therapeutics (VTVT) United States $0.062B 0.00
Curis (CRIS) United States $0.061B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.061B 0.00
Ophthotech (ISEE) United States $0.060B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.059B 0.00
Evogene (EVGN) Israel $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.057B 0.00
Moleculin Biotech (MBRX) United States $0.055B 0.00
Prima BioMed (IMMP) Australia $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.050B 0.00
HOTH THERAPEUTC (HOTH) United States $0.050B 0.00
Celldex Therapeutics (CLDX) United States $0.049B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
AZURRX BIOPHARM (AZRX) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.047B 0.00
Clearside Biomedical (CLSD) United States $0.047B 0.00
Celsion (CLSN) United States $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
ANCHIANO THERAP (ANCN) Israel $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
VIVUS (VVUS) United States $0.038B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Leap Therapeutics (LPTX) United States $0.037B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 0.00
Aptevo Therapeutics (APVO) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Motif Bio Plc (MTFB) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Sophiris Bio (SPHS) United States $0.029B 0.00
GTx (GTXI) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Adial Pharmaceuticals (ADIL) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Vical (VICL) United States $0.025B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
Oragenics (OGEN) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
TRACON Pharmaceuticals (TCON) United States $0.020B 0.00
IMMURON LTD (IMRN) Australia $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
TrovaGene (TROV) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
Vital Therapies (IMUX) United States $0.018B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
BioPharmX (BPMX) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.96
Dare Bioscience (DARE) United States $0.012B 0.00
Neuralstem (CUR) United States $0.011B 0.00
Flex Pharma (FLKS) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
RestorGenex (DFFN) United States $0.009B 0.00
Edge Therapeutics (PDSB) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00